P3 Health Partners Inc. Class A (PIII)
NASDAQ: PIIIHealth CareMedical/Nursing ServicesUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
PIII stock chart
Technical analysisKey statistics
All statistics- Market cap
- $350.24M
- EPS (TTM)
- -$23.21
- Dividend yield
- None
- 52-week range
- 1.52 – 16.89
- Day range
- 1.63 – 1.84
- Volume / Avg
- 23.18K / 30.85K
- Beta
- —
- Shares outstanding
- 4.02M
52-week range
PIII stock today
On Nov 20, PIII ended the session at $1.69, shedding $0.17 (9.14%), versus the S&P 500's 3.70% decline. Shares are 90.0% below their 52-week high of $16.89, set on May 28, 2026 and 11.2% above the 52-week low of $1.52, near the bottom of the past year's range. PIII is down 51.6% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 70.4%.
P3 Health Partners has posted a net loss over the last twelve months (EPS of -$23.21), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About P3 Health Partners
Company profileP3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. The company was founded in 2020 and is based in Henderson, Nevada.
- Sector
- Health Care
- Industry
- Medical/Nursing Services
- CEO
- Dr. Aric Coffman M.D.
- Headquarters
- Henderson, NV
- Employees
- 320
- IPO year
- 2021
- Website
- p3hp.org
Financial highlights
Full financialsIn fiscal 2024, P3 Health Partners generated $1.46 billion in revenue, down 2.8% from fiscal 2024, the first decline in the 6 years shown. P3 Health Partners reported a net loss of $147.9 million, compared with a loss of $135.8 million a year earlier. Operating margin was -18.5%.
| Fiscal year | FY 2024 | FY 2024 | FY 2023 | FY 2022 | FY 2020 |
|---|---|---|---|---|---|
| Revenue | $1.46B | $1.50B | $1.27B | $1.05B | $491.06M |
| Growth | -2.76% | +18.48% | +20.67% | +113.71% | +237.54% |
| Net income | $-147.95M | $-135.85M | $-57.77M | $-270.13M | $-31.41M |
| EPS (diluted) | $-45.26 | $-54.06 | $-0.63 | $-6.50 | — |
Analyst forecast
ForecastConsensus (2 analysts)
buy
Avg. price target
$7.75+358.58%
- Strong buy 0
- Buy 1
- Hold 1
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Nov 9, 2026
- EPS actual vs est.
- $0.07 vs —
PIII news
All PIII news- P3 Health Partners beats top-line and bottom-line estimates; updates FY26 outlookSeeking Alpha
- P3 Health Partners Inc. Reports Third Quarter 2026 Net Income of $30.8 million and Raises Adjusted EBITDA Guidance MidpointNasdaq
- P3 Health (PIII) Q3 2026 Earnings Call TranscriptNasdaqPIII, ET
- P3 Health Partners raises 2026 adjusted EBITDA guidance range to $90M-$110M as it targets $200M in value creationSeeking Alpha
- P3 Health Partners Announces Third Quarter 2026 ResultsBusiness Wire
- P3 Health Partners Schedules Third Quarter 2026 Earnings Release and Conference CallBusiness Wire
P3 Health Partners peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| STLNStarling Oncology Inc. | 3.00 | -5.66% | $305.97M | vs PIII |
| SRTAStrata Critical Medical Inc. Class A | 4.56 | -5.59% | $407.30M | vs PIII |
| AUNAAuna SA Class A | 3.66 | -6.15% | $271.05M | vs PIII |
| SBCSBC Medical Group Holdings Incorporated | 5.17 | -7.68% | $530.32M | vs PIII |
| LFMDLifeMD Inc. | 1.45 | -9.40% | $69.84M | vs PIII |
| NAKANakamoto Inc. | 3.44 | -15.89% | $63.11M | vs PIII |
| EUDAEUDA Health Holdings Limited Class A | 15.96 | -7.69% | $47.79M | vs PIII |
| AIRSAirSculpt Technologies Inc. | 0.5907 | -9.72% | $43.67M | vs PIII |
Indexes, lists and sector
P3 Health Partners stock FAQ
What is P3 Health Partners's stock price today?
PIII last traded at $1.69 as of Nov 20, 4:00 PM EST, down 9.14% on the day. Prices are delayed at least 15 minutes.
Does P3 Health Partners pay a dividend?
No. P3 Health Partners does not currently pay a regular cash dividend.
Who is P3 Health Partners's CEO?
Dr. Aric Coffman M.D. is the chief executive officer of P3 Health Partners Inc. Class A, which has about 320 employees.
Has PIII ever split its stock?
Yes. The most recent PIII stock split was a 1-for-50 split on Apr 14, 2025.
What is the PIII 52-week high?
The 52-week high for PIII is $16.89 and the 52-week low is $1.52. The stock is currently 90.0% below its high.